Peppermint

Clinical research startup Peppermint has raised $4.7 million in seed funding to solve a costly problem in clinical trials: hospitals and research sites often wait months to collect payments for work they’ve already completed.

Clinical research startup Peppermint has raised $4.7 million in seed funding to solve a costly problem in clinical trials: hospitals and research sites often wait months to collect payments for work they've already completed. The San Francisco-based startup is using AI to automate billing, track outstanding payments, and help research organizations get paid faster. The